Exicure Receives Nasdaq Delinquency Notice; Stock Down

June 02, 2026 — 05:40 am EDT

Written by RTTNews.com for RTTNews

(RTTNews) - Exicure, Inc. (XCUR), an early-stage biotechnology company, announced that it received a notification letter from the Listing Qualifications Department of the Nasdaq on May 28, 2026, stating the company was not in compliance with Nasdaq Listing rules due to the delayed filing of its quarterly Report on Form 10-Q for the three months ended March 31, 2026.

Exicure noted that the delay was primarily due to the additional time required following changes in the financial reporting personnel and related filing procedures.

Following that, on May 29, 2026, the company filed its quarterly Report on Form 10-Q for the three months ended March 31, 2026, with the Securities and Exchange Commission and expects to have regained compliance with the Nasdaq Listing Rule.

XCUR has traded between $2.62 and $10.80 over the last year. The stock closed Monday's trade at $3.33, up 4.39%.

In the pre-market, XCUR is down 3.90% at $3.20.

For More Such Biotech Stock News, visit rttnews.com.

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Exicure Receives Nasdaq Delinquency Notice; Stock Down

Tags

Latest Articles